Catalyst Pharmaceutical Partners shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Catalyst Pharmaceutical Partners
Tip: Access up to 7 years of quarterly data
All positions including Catalyst Pharmaceutical Partners held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Catalyst Pharmaceutical Partners by Goldman Sachs Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $29M | 1.5M | 19.88 |
2024-06-30 | $17M | 1.1M | 15.49 |
2024-03-31 | $16M | 1.0M | 15.94 |
2023-12-31 | $16M | 958k | 16.81 |
2023-09-30 | $11M | 968k | 11.69 |
2023-06-30 | $17M | 1.3M | 13.44 |
2023-03-31 | $19M | 1.1M | 16.58 |
2022-12-31 | $14M | 764k | 18.60 |
2022-06-30 | $13M | 1.9M | 7.01 |
2022-03-31 | $9.1M | 1.1M | 8.29 |
2021-12-31 | $4.9M | 722k | 6.77 |
2021-09-30 | $3.8M | 715k | 5.30 |
2021-03-31 | $6.6M | 1.4M | 4.61 |
2020-12-31 | $11M | 3.2M | 3.34 |
2020-09-30 | $7.5M | 2.5M | 2.97 |
2020-06-30 | $9.6M | 2.1M | 4.62 |
2019-12-31 | $7.2M | 1.9M | 3.75 |
2019-09-30 | $5.1M | 968k | 5.31 |
2019-06-30 | $236k | 62k | 3.84 |
2019-03-31 | $447k | 88k | 5.11 |
2018-12-31 | $99k | 53k | 1.88 |
2018-09-30 | $1.3M | 339k | 3.78 |
2018-06-30 | $1.4M | 459k | 3.12 |
2018-03-31 | $1.0M | 437k | 2.39 |
2017-12-31 | $1.4M | 366k | 3.91 |
2017-09-30 | $115k | 46k | 2.52 |
2017-06-30 | $52k | 19k | 2.76 |
2017-03-31 | $36k | 19k | 1.93 |
2016-12-31 | $45k | 43k | 1.05 |
2016-09-30 | $189k | 173k | 1.09 |
2016-06-30 | $135k | 190k | 0.71 |
2016-03-31 | $119k | 102k | 1.17 |
2015-12-31 | $68k | 28k | 2.44 |
2015-06-30 | $49k | 12k | 4.10 |
2015-03-31 | $446k | 103k | 4.33 |
2014-12-31 | $56k | 19k | 2.99 |
Top funds holding Catalyst Pharmaceutical Partners
View all funds holding Catalyst Pharmaceutical Partners